Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $65.50 $77.98 Friday, 10th May 2024 AXSM stock ended at $72.50. This is 1.60% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.90% from a day low at $72.40 to a day high of $75.95.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jun 01, 2016 $7.84 $7.92 $7.58 $7.78 33 690
May 31, 2016 $7.95 $8.21 $7.28 $7.85 90 606
May 27, 2016 $8.81 $8.85 $7.03 $8.02 78 413
May 26, 2016 $8.96 $8.90 $8.30 $8.77 32 755
May 25, 2016 $9.75 $9.75 $8.31 $8.99 61 241
May 24, 2016 $10.13 $10.40 $9.73 $9.95 59 418
May 23, 2016 $10.38 $10.85 $9.80 $10.30 48 767
May 20, 2016 $10.13 $10.50 $9.81 $10.30 8 392
May 19, 2016 $10.53 $11.00 $9.76 $10.02 31 041
May 18, 2016 $10.45 $10.44 $9.59 $9.94 6 773
May 17, 2016 $10.16 $11.00 $10.38 $10.47 10 319
May 16, 2016 $10.74 $10.68 $10.00 $10.17 8 616
May 13, 2016 $11.31 $11.50 $10.65 $10.65 18 573
May 12, 2016 $11.08 $11.39 $11.01 $11.39 9 676
May 11, 2016 $11.12 $11.52 $10.94 $11.18 11 453
May 10, 2016 $11.20 $11.55 $10.73 $11.09 21 990
May 09, 2016 $11.34 $11.68 $10.99 $11.08 53 803
May 06, 2016 $11.08 $11.59 $10.77 $11.37 15 584
May 05, 2016 $10.56 $11.56 $10.40 $11.20 14 370
May 04, 2016 $10.48 $11.75 $10.33 $11.15 19 085
May 03, 2016 $11.55 $11.75 $10.40 $10.57 14 382
May 02, 2016 $11.57 $11.95 $11.13 $11.15 22 133
Apr 29, 2016 $12.20 $12.50 $11.10 $11.45 12 298
Apr 28, 2016 $12.44 $12.45 $12.03 $12.41 9 489
Apr 27, 2016 $10.59 $12.69 $10.59 $12.44 14 589
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT